See the DrugPatentWatch profile for cosentyx

Based on the information available, it is recommended to consult with a healthcare provider before receiving any vaccines while on Cosentyx (secukinumab) [1]. Cosentyx is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug called a monoclonal antibody, which works by targeting a specific molecule in the body's immune system [1].

According to the manufacturer's prescribing information, there is limited data on the use of Cosentyx in patients receiving vaccinations [2]. The manufacturer states that "the safety and immunogenicity of Cosentyx have not been established in patients receiving concurrent live or inactivated vaccines" [2]. Therefore, it is unclear how vaccines may interact with Cosentyx and its effectiveness in patients receiving vaccinations [2].

It is important to note that the Centers for Disease Control and Prevention (CDC) recommends that individuals taking immunosuppressive drugs, such as Cosentyx, receive inactivated or recombinant vaccines, rather than live-virus vaccines [3]. However, the CDC also recommends consulting with a healthcare provider to determine the appropriate vaccination schedule for individuals taking immunosuppressive drugs [3].

In summary, while there is limited data on the use of Cosentyx in patients receiving vaccinations, it is recommended to consult with a healthcare provider before receiving any vaccines while on Cosentyx. Healthcare providers will consider the patient's individual circumstances and make recommendations based on the most up-to-date information available.

Sources:

[1] Novartis Pharmaceuticals Corporation. Cosentyx (secukinumab) [prescribing information]. 2021. Available at: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.

[2] Novartis Pharmaceuticals Corporation. Cosentyx (secukinumab) [full prescribing information]. 2021. Available at: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx-full-prescribing-information.pdf>.

[3] Centers for Disease Control and Prevention. Vaccination of persons with weakened immune systems. 2022. Available at: <https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html>.